These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 22000322)
41. Synthesis and biological activities of pyrazolo[3,4-g]quinoxaline derivatives. Gavara L; Saugues E; Alves G; Debiton E; Anizon F; Moreau P Eur J Med Chem; 2010 Nov; 45(11):5520-6. PubMed ID: 20864224 [TBL] [Abstract][Full Text] [Related]
42. Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell line. Schenone S; Bruno O; Bondavalli F; Ranise A; Mosti L; Menozzi G; Fossa P; Donnini S; Santoro A; Ziche M; Manetti F; Botta M Eur J Med Chem; 2004 Nov; 39(11):939-46. PubMed ID: 15501543 [TBL] [Abstract][Full Text] [Related]
43. Synthesis and biological evaluation of some novel polysubstituted pyrimidine derivatives as potential antimicrobial and anticancer agents. Rostom SA; Ashour HM; Abd El Razik HA Arch Pharm (Weinheim); 2009 May; 342(5):299-310. PubMed ID: 19415663 [TBL] [Abstract][Full Text] [Related]
44. A convenient synthesis and molecular modeling study of novel pyrazolo[3,4-d]pyrimidine and pyrazole derivatives as anti-tumor agents. Nassar IF; Atta-Allah SR; Elgazwy AS J Enzyme Inhib Med Chem; 2015 Jun; 30(3):396-405. PubMed ID: 25068728 [TBL] [Abstract][Full Text] [Related]
45. Synthesis of some new pyrazolo[3,4-d]pyrimidine derivatives of expected anticancer and radioprotective activity. Ghorab MM; Ragab FA; Alqasoumi SI; Alafeefy AM; Aboulmagd SA Eur J Med Chem; 2010 Jan; 45(1):171-8. PubMed ID: 19853327 [TBL] [Abstract][Full Text] [Related]
46. Synthesis and biological evaluation of 2,4-diamino-6-(arylaminomethyl)pyrido[2,3-d]pyrimidines as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase and as antiopportunistic infection and antitumor agents. Gangjee A; Adair OO; Queener SF J Med Chem; 2003 Nov; 46(23):5074-82. PubMed ID: 14584957 [TBL] [Abstract][Full Text] [Related]
47. Synthesis and antiproliferative activity of benzo[d]isothiazole hydrazones. Vicini P; Incerti M; Doytchinova IA; La Colla P; Busonera B; Loddo R Eur J Med Chem; 2006 May; 41(5):624-32. PubMed ID: 16540208 [TBL] [Abstract][Full Text] [Related]
48. Novel N2-substituted pyrazolo[3,4-d]pyrimidine adenosine A3 receptor antagonists: inhibition of A3-mediated human glioblastoma cell proliferation. Taliani S; La Motta C; Mugnaini L; Simorini F; Salerno S; Marini AM; Da Settimo F; Cosconati S; Cosimelli B; Greco G; Limongelli V; Marinelli L; Novellino E; Ciampi O; Daniele S; Trincavelli ML; Martini C J Med Chem; 2010 May; 53(10):3954-63. PubMed ID: 20408530 [TBL] [Abstract][Full Text] [Related]
49. Synthesis of some pyrazolines and pyrimidines derived from polymethoxy chalcones as anticancer and antimicrobial agents. Rostom SA; Badr MH; Abd El Razik HA; Ashour HM; Abdel Wahab AE Arch Pharm (Weinheim); 2011 Sep; 344(9):572-87. PubMed ID: 21755528 [TBL] [Abstract][Full Text] [Related]
50. Synthesis and anticancer activity of novel tetralin-6-ylpyridine and tetralin-6-ylpyrimidine derivatives. Amin KM; El-Zahar MI; Anwar MM; Kamel MM; Mohamed MH Acta Pol Pharm; 2009; 66(3):279-91. PubMed ID: 19645328 [TBL] [Abstract][Full Text] [Related]
51. Anticancer activities of some newly synthesized pyrazole and pyrimidine derivatives. Mohamed AM; El-Sayed WA; Alsharari MA; Al-Qalawi HR; Germoush MO Arch Pharm Res; 2013 Sep; 36(9):1055-65. PubMed ID: 23737106 [TBL] [Abstract][Full Text] [Related]
52. Synthesis of novel thiazolyl-pyrimidines and their anticancer activity in vitro. Shi HB; Li HB; Lu KQ; Zhu XR; Hu WX; Pei W Arch Pharm (Weinheim); 2011 Oct; 344(10):675-83. PubMed ID: 21984017 [TBL] [Abstract][Full Text] [Related]
53. Synthesis of new pyrazole derivatives and their anticancer evaluation. Nitulescu GM; Draghici C; Missir AV Eur J Med Chem; 2010 Nov; 45(11):4914-9. PubMed ID: 20728965 [TBL] [Abstract][Full Text] [Related]
54. Synthesis, structure-activity relationships, and antitumor studies of 2-benzoxazolyl hydrazones derived from alpha-(N)-acyl heteroaromatics. Easmon J; Pürstinger G; Thies KS; Heinisch G; Hofmann J J Med Chem; 2006 Oct; 49(21):6343-50. PubMed ID: 17034140 [TBL] [Abstract][Full Text] [Related]
55. Synthesis and biological evaluation of 2,4,6-functionalized derivatives of pyrido[2,3-d]pyrimidines as cytotoxic agents and apoptosis inducers. Sanmartín C; Domínguez MV; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA Arch Pharm (Weinheim); 2008 Jan; 341(1):28-41. PubMed ID: 18161903 [TBL] [Abstract][Full Text] [Related]
56. Inhibition of Bcr-Abl phosphorylation and induction of apoptosis by pyrazolo[3,4-d]pyrimidines in human leukemia cells. Manetti F; Pucci A; Magnani M; Locatelli GA; Brullo C; Naldini A; Schenone S; Maga G; Carraro F; Botta M ChemMedChem; 2007 Mar; 2(3):343-53. PubMed ID: 17295370 [TBL] [Abstract][Full Text] [Related]
57. Anticancer phytochemical analogs 37: synthesis, characterization, molecular docking and cytotoxicity of novel plumbagin hydrazones against breast cancer cells. Dandawate P; Ahmad A; Deshpande J; Swamy KV; Khan EM; Khetmalas M; Padhye S; Sarkar F Bioorg Med Chem Lett; 2014 Jul; 24(13):2900-4. PubMed ID: 24835626 [TBL] [Abstract][Full Text] [Related]
58. Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives. Congiu C; Onnis V; Vesci L; Castorina M; Pisano C Bioorg Med Chem; 2010 Sep; 18(17):6238-48. PubMed ID: 20702096 [TBL] [Abstract][Full Text] [Related]